Upload
myrna
View
30
Download
2
Tags:
Embed Size (px)
DESCRIPTION
Progress and retooling needs as perceived by developers. Retooling Task Force work planning meeting 15-16 January 2008. Dr Giorgio Roscigno CEO – FIND. FIND’s perspective:. - PowerPoint PPT Presentation
Citation preview
Progress and retooling needs as Progress and retooling needs as perceived by developersperceived by developers
Retooling Task Force work planning meeting
15-16 January 2008
Dr Giorgio RoscignoCEO – FIND
Health Health PostPost
ReferralReferralHospitalHospital
MicroscopyMicroscopyCenterCenter
20122007 2009 2010Level
AntibodyDetection
AntigenDetection
Eiken NAAT
Zeiss LED
MGIT MTB/DST
Capilia
Biotec DST
Projects 20112008
Hain DST
Quantiferon
Cepheid NAAT
Evaluation
Access
AccessSTAG
Demonstration AccessSTAG
Demonstration AccessSTAG
Feasibility &Development
Evaluation Demo AccessSTAG
EvaluationFeasibility Develop Demonstration AccessSTAG
EvaluationFeasibility &Development Demonstration AccessSTAG
EvaluationFeasibility & Development Demonstration AccessSTAG
EvaluationFeasibility & Development Demonstration AccessSTAG
I
A
ASTAG Impact
IImpact
IImpact
IImpact
A
A
ImpactDemonstration Access ASTAG
IImpactA
IImpact
IImpact
A
A
FIND has a rich set of products in the pipeline intended for the different levels of the health system which are developed and evaluated following a well-defined process from feasibility onwards…
FIND’s perspective:
Project phases & milestones
PHASES
Milestones
Output
FIND
FeasibilityContract
phase Development
phaseEvaluation
phaseDemonstration
phaseGlobal Policy
2 3 654 71
Cu
stom
er R
equ
iremen
ts
Sp
ecification
s
8
National Practice
Impact
Cu
stom
er sup
po
rt d
ocu
men
t
WH
O g
uid
elines
Effectiven
ess
Efficacy
Pro
du
ct in b
ox
Effe
ctivene
ss &
Access
Registration
Customer support documentMarketing
plan
FeasibilityContract
phase Development
phaseEvaluation
phaseDemonstration
phaseGlobal Policy
2 3 654 71
Cu
stom
er R
equ
iremen
ts
Sp
ecification
s
8
National Practice
Impact
Cu
stom
er sup
po
rt d
ocu
men
t
WH
O g
uid
elines
Effectiven
ess
Efficacy
Pro
du
ct in b
ox
Effe
ctivene
ss &
Access
Registration
Customer support document
FINDPARTNERSPARTNERS
Marketing plan
Partnership Strategy
But achieving impact requires engagement with the retooling process, once new tools are adopted into global policy
Laboratory preparedness for introduction of new technologies requires addressing:
• Infrastructure and equipment
• Staffing and training• Biosafety aspects• Development of SOPs• QA systems
At the appropriate level of the health care system
(Hardware)
(Software)
Adoption into globalPolicy
Global Impact
Collecting evidence for scaling up
• Uptake in pilot countries• Accreditation /franchising• Laboratory Support• Measuring Impact
Development, Evaluation, Demonstrationphases
WHO
Link to PEPFAR, Global Fund, other initiatives
Scaling up and continued adoption
FIND’s approach:
• Facilitate introduction of new technologies in selected countries
• Concentrate on “software”, and collaborate with partners who can provide “hardware”
• Document experience and knowledge for widescale replication elsewhere
And is based on:– Product requirements– Local needs and capacity– Level of healthcare system where product will be used– Collaboration with Ministries of Health based on a signed MOU– Adapted to the national context
Emerging Economies Low-income/Asia Low-income/Africa
China, India, S. Africa, Russia, Brazil Indonesia, Bangladesh, Pakistan, Philippines, Afghanistan, Cambodia, Myanmar, Vietnam, etc.
DR Congo, Ethiopia, Kenya, Mozambique, Nigeria, Uganda, Tanzania, etc.
• Better funding available, mostly from national budget
• Human resource capacity stronger• Private for-profit sector role often
considerable
• More dependent on international donors for funding
• Moderate human resource capacity• Current lab services weak to moderate• Private for-profit role significant
• Very dependent on international donors• Generally weak human resource
capacity• Current lab services weak• Private for-profit role present, but
variable
• Large NTLP with established reference lab (#8/22 HBC)
• PEPFAR and other partners present with support for HIV/AIDS and TB programs
• NTLP identified continued gap on “software” side
NTLP has requested support from FIND to:•Provide long term, technical assistance over many months
•Support integration of new diagnostic technologies into NTLP at reference (automated liquid culture) and regional levels (manual liquid culture)
FIND approach to retooling: Example 1: Ethiopia
• No TB reference laboratory existed
• Focus was on referral level
Please refer to WHO presentation
FIND approach to retooling: Example 2: Lesotho
• Large NTLP (#14/22 HBC)
• Multiple partners present with resources for infrastructure, equipment procurement
• NTLP turned to FIND for support with “software”
In collaboration with other partners, FIND is:•Supporting national referral laboratory for preparation for introduction of liquid culture, including: planning for upgrading infrastructure to meet bio-safety requirements (see next)
•Reinforcing quality assurance systems
FIND approach to retooling: Example 3: Tanzania
– Excellent in case finding with a quality assured microscopy services offered in more than 12000 microscopy centres under the NTP
– But fewer competent NRLs
FIND input:
MOU signed with the Health Ministry Government of India and State Government of Rajasthan
FIND/INDIA office started in New Delhi on 1st Oct,2007
Step 1 - Introduce novel technology at all 3 GLC identified DOTS plus sites in Delhi , Ahmadabad and Nagpur & establish a training site in Jaipur, Rajasthan
Appoint Microbiologists at the above sites and a study coordinator
FIND approach to retooling: Example 4: India
FIND’s perspective on retooling: Conclusion
Adoption into globalPolicy
Collecting evidence for scaling up
Global Impact
• Uptake in pilot countries• Accreditation /franchising• Laboratory Support• Measuring Impact
Development, Evaluation, Demonstrationphases
WHO
Link to PEPFAR, Global Fund, other initiatives
Scaling up and continued adoption
FIND
Partners
FIND
Partners
Retooling to prepare laboratories for the introduction of new diagnostic technologies cannot be done alone…but in partnership